Synthetic Biologics' (SYN) Management On Q1 2018 Results - Earnings Call Transcript | Latest News RSS feed

Synthetic Biologics' (SYN) Management On Q1 2018 Results - Earnings Call Transcript - Latest News


Synthetic Biologics' (SYN) Management on Q1 2018 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (NYSEMKT:SYN) Q1 2018 Earnings Conference Call May 8, 2018 4:30 PM ET Executives Vincent Perrone – Director-Corporate Communication Steven Shallcross – Acting Chief Executive ... read more

Synthetic Biologics : Announces Management Changes

Keywords for this news article include: Biotechnology, Bioengineering, Genetic Engineering, Synthetic Biologics Inc, Genetically-Engineered Proteins. read more

Synthetic Biologics : Provides Update on Development of SYN-004 (ribaxamase), for the Prevention of C. difficile Infection

ROCKVILLE, Md., April 23, 2018 /PRNewswire/ -- Synthetic Biologics, Inc. , a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and ... 2018 Log in E-ma... read more

Looking for another news?


Synthetic Biologics Inc. (SYN) Management on Q2 2018 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (NYSEMKT:SYN) Q2 2018 Earnings Conference Call August 8 ... I will review our financial results for the period ending June 30, 2018. Financial stewardship and cash management ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us